Skip to main content

Day: May 16, 2023

Nearly 15% of Consumers Allow Auto Insurance Coverage to Lapse as Shopping Fails to Yield Lower Rates

New TransUnion report finds consumers also increasingly turn to insurance agents for guidance on savings CHICAGO, May 16, 2023 (GLOBE NEWSWIRE) — Auto and property insurance shopping rates continued to rise in Q1 2023, up 7% and 10%, respectively, compared to Q1 2022. However, as shopping has increased, the number of consumers switching carriers is beginning to decrease, indicating that premiums are rising among virtually all insurers. The findings are part of TransUnion’s (NYSE: TRU) latest quarterly Insurance Personal Lines Trends and Perspectives Report, which includes trends in the auto and property insurance industries, as well as survey data about consumers’ behaviors and attitudes. The survey found nearly 15% of consumers owned or used a vehicle without valid coverage or had allowed their coverage to lapse within the past...

Continue reading

Akari Therapeutics to Participate in A.G.P.’s Virtual Healthcare Conference

NEW YORK and LONDON, May 16, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that the company will participate in Alliance Global Partners’ Virtual Healthcare Conference being held May 23-24, 2023. During the event, the Akari management team will attend 1:1 investor meetings. About Akari Therapeutics Akari Therapeutics, plc (Nasdaq: AKTX) is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Akari’s lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari’s pipeline includes a Phase 3 clinical trial program investigating nomacopan for severe pediatric hematopoietic...

Continue reading

Cerence Ride to Bring Conversational AI Experience to Loncin Motorcycles Worldwide

Cerence continues to grow its presence in two-wheeler market; enables Loncin Motors to export advanced, multi-language conversational AI that keeps riders safe and connected BURLINGTON, Mass., May 16, 2023 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced Chinese OEM Loncin Motors has selected Cerence Ride to enable AI-powered voice interaction for riders of its high-end motorcycle line. With Cerence Ride, Loncin riders can stay focused on the road with their hands on the handlebars, while still staying informed, entertained and connected to their digital lives. A global provider of two-wheelers, Loncin required a conversational AI partner who could flexibly integrate with its operating systems and ensure clear communication despite the noisy environment motorcycle riders experience on the...

Continue reading

FOREWARN Partners with Gulf Coast MLS

Alabama-based Association contracts to make FOREWARN services available for its 2,200+ real estate professional Participants and Subscribers to promote proactive agent safety BOCA RATON, Fla., May 16, 2023 (GLOBE NEWSWIRE) — FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Gulf Coast MLS (“GCMLS”) has contracted to make FOREWARN® services available for the 2,200+ Participants and Subscribers they serve throughout Mobile and the surrounding area to promote proactive real estate agent safety. Available both online and through a mobile application, FOREWARN analyzes billions of data points and provides users with the ability to mitigate risks by verifying identity, searching for criminal histories, and validating information...

Continue reading

New Long-Reaching USB 3.2 Compatible Reclocker/Redriver Devices for Automotive and Industrial Applications

Microchip’s EQCO510 and EQCO5X31 devices offer a solid two-channel solution to send high-speed data signals up to 15 meters in both directions CHANDLER, Ariz., May 16, 2023 (GLOBE NEWSWIRE) — The standard universal serial bus or USB connection is an industry mainstay that transfers data between two devices. The increase of adding electronic components to applications across the automotive, industrial and consumer industries has spurred the need for far-reaching USB cabling products. To provide long-distance and reliable USB solutions to the market, Microchip Technology (Nasdaq: MCHP) today announces two new reclocker/redriver devices. The automotive EQCO510 and industrial EQCO5X31 reclocker/redriver devices extend USB coverage up to 15 meters for maximum reach and are compatible with the USB 3.2 Generation 1 SuperSpeed protocol. The...

Continue reading

Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward

Cytek Aurora CS Cytek® has shipped its 100th Cytek Aurora CS system. Built on the same Full Spectrum Profiling™ technology comprising Cytek’s Aurora cell analysis system, the Aurora CS delivers high-sensitivity capabilities at the single-cell level to resolve and sort even the most challenging cell populations.FREMONT, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has shipped its 100thCytek Aurora CS system. This milestone is a clear indication of the company’s continuing momentum – and of the scientific community’s desire for Full Spectrum Profiling™ (FSP™) technology that streamlines workflows, accelerates discoveries and maximizes efficiency. Launched in June 2021, the Cytek Aurora CS is built on the same...

Continue reading

Reviv3 Announces Distribution Agreement with Kroll International for AXIL Hearing Protection and Enhancement Products

LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) — Reviv3 Procare Company (“Reviv3” or the “Company”) (OTCQB: RVIV), an emerging global e-commerce consumer products company, entered into a distribution agreement with Kroll International, a leading wholesale distributor of law enforcement, public safety, military, homeland security, and shooting sports products, to distribute AXIL hearing enhancement and protection products. “We are excited to welcome Kroll to our family of partners,” said Reviv3 CEO Jeff Toghraie. “This agreement further expands our hearing enhancement and protection solutions in the vital public safety and security markets. I am grateful to the Kroll team for sharing our vision and to our AXIL innovation team for their continued commitment to bring enhanced capability hearing solutions to our customers.” AXIL...

Continue reading

Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alpha in Non-Small Cell Lung Cancer

Media Release SYDNEY, AUSTRALIA, May 16, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive feedback from the US Food and Drug Administration (FDA), regarding the Company’s late-stage clinical development plans for its first-in-class soluble LAG-3 protein and MHC Class II agonist, eftilagimod alpha (“efti”), for the treatment of 1st line non-small cell lung cancer (NSCLC). The FDA is supportive of a registrational trial to evaluate efti in combination with an anti-PD-1 therapy based on the encouraging data from the Phase II TACTI-002, Part A (N=114) in 1st line NSCLC patients, no matter their level of PD-L1 expression, presented...

Continue reading

Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA

Multinational operator has been granted Brazilian GMP certification by ANVISA for the manufacturing of cannabis productsClever Leaves is the first and only medicinal cannabis company globally who has GMP certifications from the EU, Colombia and Brazil TOCANCIPÁ, Colombia, May 16, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that the Company has received the Brazilian GMP certification by ANVISA, the Brazilian Health Regulatory Agency, to manufacture cannabis products for Brazilian patients. Similar to the strict standards of the EU-GMP certification, ANVISA’s Brazilian-GMP certification ensures that patients receive the highest quality of medicine by preventing cases of product contamination, variations in compounds concentrations, mix-ups, incorrect...

Continue reading

Erasca Further Strengthens Business Leadership with Two Key Promotions

David Chacko, M.D., previously Erasca’s Chief Financial Officer, has been promoted to the dual position of Chief Financial Officer and Chief Business Officer Nik Chetwyn, Ph.D., previously Erasca’s SVP of Operations, has been promoted to Chief Operating Officer SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that David Chacko, M.D., previously chief financial officer (CFO) of Erasca, has been promoted to the dual position of CFO and chief business officer, and Nik Chetwyn, Ph.D., previously senior vice president of operations of Erasca, has been promoted to chief operating officer, with each promotion being effective as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.